Methanogens are members ofthe human microbiome and the only known source of biogenic methane. Residing in the third domain of life, Archaea, they are strict anaerobes that have evolved systems to combat periodic oxygen exposure. There is a signiflcant gap in our knowledge of how methanogens mount a transcriptional response that ultimafiey leads to cell survival during periods of oxygen stress. The overall goal of this project is to understand the role of MsvR in regulating the oxidative stress response in methanogenic Archaea through structure/funcfion analysis. MsvR is a newly described transcripfional regulator present in select methanogens including those residing within the human intesfine and oral cavity. Early characterization of MsvR has led to the development ofthe following hypotheses: HI) mulfiple amino acid residues in MsvR play a role in its funcfion as a transcriptional regulator, (H2) oxidized and reduced MsvR play disfinct yet integral roles in the regulafion of expression of at least two promoters, and (H3) MsvR undergoes various conformational changes when shifting between the oxidized and reduced states that impact its funcfion. To address these hypotheses the following specific aims are proposed:
(Aim 1) Determine the 3D structure of MsvR by X-ray crystallography, (Aim 2) Identify additional amino acid residues or combinafions thereof in MsvR necessary for funcfion, (Aim 3) Identiflcation of disulfide bonds formed upon oxidative stress and the role of oxidized vs. reduced MsvR in transcription regulafion, (Aim 4) Identificafion of conformational changes in MsvR.
As potentially secondary contributors to pathogenesis, it is critical to gain a better understanding of how methanogens withstand intermittent encounters with oxygen. Additionally these organisms likely possess very sensitive mechanisms to sense changes in cellular redox that may provide insight into subtle changes in redox balance that play a role in aging and disease.
|Guillen, Katrin P; Ruben, Eliza A; Virani, Needa et al. (2017) Annexin-directed ?-glucuronidase for the targeted treatment of solid tumors. Protein Eng Des Sel 30:85-94|
|Sundaresan, Ramya; Parameshwaran, Hari Priya; Yogesha, S D et al. (2017) RNA-Independent DNA Cleavage Activities of Cas9 and Cas12a. Cell Rep 21:3728-3739|
|Van Orden, Mason J; Klein, Peter; Babu, Kesavan et al. (2017) Conserved DNA motifs in the type II-A CRISPR leader region. PeerJ 5:e3161|
|Murugan, Karthik; Babu, Kesavan; Sundaresan, Ramya et al. (2017) The Revolution Continues: Newly Discovered Systems Expand the CRISPR-Cas Toolkit. Mol Cell 68:15-25|
|Wang, Bing; Powell, Samantha M; Guan, Ye et al. (2017) Nitrosoamphetamine binding to myoglobin and hemoglobin: Crystal structure of the H64A myoglobin-nitrosoamphetamine adduct. Nitric Oxide 67:26-29|
|Li, Yangxiong; Lavey, Nathan P; Coker, Jesse A et al. (2017) Consequences of Depsipeptide Substitution on the ClpP Activation Activity of Antibacterial Acyldepsipeptides. ACS Med Chem Lett 8:1171-1176|
|Terzyan, Simon S; Cook, Paul F; Heroux, Annie et al. (2017) Structure of 6-diazo-5-oxo-norleucine-bound human gamma-glutamyl transpeptidase 1, a novel mechanism of inactivation. Protein Sci 26:1196-1205|
|Motley, Jeremy L; Stamps, Blake W; Mitchell, Carter A et al. (2017) Opportunistic Sampling of Roadkill as an Entry Point to Accessing Natural Products Assembled by Bacteria Associated with Non-anthropoidal Mammalian Microbiomes. J Nat Prod 80:598-608|
|Mooers, Blaine H M (2016) Simplifying and enhancing the use of PyMOL with horizontal scripts. Protein Sci 25:1873-82|
|Lavey, Nathan P; Coker, Jesse A; Ruben, Eliza A et al. (2016) Sclerotiamide: The First Non-Peptide-Based Natural Product Activator of Bacterial Caseinolytic Protease P. J Nat Prod 79:1193-7|
Showing the most recent 10 out of 41 publications